Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
-44.76M
Cash
181.7M
Avg Qtr Burn
-11.48M
Short % of Float
23.79%
Insider Ownership
7.51%
Institutional Own.
80.53%
Qtr Updated
09/30/24
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
ALTO-300 Details Major depressive disorder | Phase 2b Data readout | |
ALTO-100 Details Major depressive disorder | Phase 2b Update | |
ALTO-101 Details Cognitive Impairment Associated with Schizophrenia | Phase 2 Data readout | |
ALTO-203 Details Major depressive disorder | Phase 2 Data readout |